JANUVIA Side Effects

7023576-7 | Pancreatitis
on Sep 30, 2010 Male patient from UNITED STATES , 57 years of age, weighting 340.0 lb, was diagnosed with diabetes mellitus, weight decreased and was treated with Januvia (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis. Januvia dosage: 100 Mg 1 X Day. During the same period patient was treated with JANUMET (100 1x Day) (View Janumet Review and Janumet Label ). Patient was hospitalized.

7023519-6 | Abdominal Pain Upper, Decreased Appetite, Nausea, Pancreatitis, Weight Decreased
Patient was taking Januvia (View Usage). Patient had the following side effects: abdominal pain upper, decreased appetite, nausea (What is nausea?), pancreatitis, weight decreased on Sep 28, 2010 from UNITED STATES Additional patient health information: Male patient , 52 years of age, weighting 174.2 lb, was diagnosed with anxiety (What is anxiety?) and. Januvia dosage: In The Morning. During the same period patient was treated with COZAAR (View Cozaar Review and Cozaar Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), HYZAAR (View Hyzaar Review and Hyzaar Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ).

7022862-4 | Cyclic Vomiting Syndrome, Pancreatitis
Adverse event was reported on Sep 24, 2010 by a Male patient taking Januvia (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 70 years of age, weighting 189.6 lb, After Januvia was administered, patient had the following side effects: cyclic vomiting syndrome, pancreatitis. During the same period patient was treated with ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), LEVEMIR (View Levemir Review and Levemir Label ), CRESTOR (View Crestor Review and Crestor Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

7020824-4 | Dementia, Echolalia, Hypokalaemia, Tremor
on Sep 23, 2010 Female patient from FRANCE , 70 years of age, weighting 143.3 lb, was diagnosed with type 2 diabetes mellitus, nephrogenic diabetes insipidus, bipolar i disorder and was treated with Januvia (View Usage). Patient experienced the following unwanted or unexpected effects: dementia (What is dementia?), echolalia, hypokalaemia, tremor. Januvia dosage: . During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), DIVALPROEX SODIUM (View Divalproex Sodium Review and Divalproex Sodium Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), REPAGLINIDE (View Repaglinide Review and Repaglinide Label ).


7020813-X | Adverse Event, Dizziness
on Sep 14, 2010 Female patient from UNITED STATES , 80 years of age, weighting 229.3 lb, was diagnosed with type 2 diabetes mellitus, deep vein thrombosis (What is deep vein thrombosis?) and was treated with Januvia (View Usage). Patient had the following side effects: adverse event, dizziness (What is dizziness?). Januvia dosage: . During the same period patient was treated with WARFARIN (View Warfarin Review and Warfarin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), OXYBUTYNIN (View Oxybutynin Review and Oxybutynin Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ).

7020808-6 | Pneumonia
Patient was taking Januvia (View Usage). After Januvia was administered, patient had the following side effects: pneumonia (What is pneumonia?) on Sep 27, 2010 from ITALY Additional patient health information: Female patient , 66 years of age, was diagnosed with type 2 diabetes mellitus and. Januvia dosage: . Patient was hospitalized.

7020567-7 | Asthenia, Atrial Fibrillation, Autonomic Nervous System Imbalance, Blood Creatinine Increased, Blood Pressure Decreased, Blood Urea Increased, Constipation, Decreased Appetite, Diabetic Neuropathy
Adverse event was reported on Sep 17, 2010 by a Female patient taking Januvia (View Usage) (Dosage: 100 Mg/daily Po ; 50 Mg/daily Po ; 50 Mg/daily Po) was diagnosed with type 2 diabetes mellitus and. Location: JAPAN , 65 years of age, Patient experienced the following unwanted or unexpected effects: asthenia, atrial fibrillation (What is atrial fibrillation?), autonomic nervous system imbalance, blood creatinine increased, blood pressure decreased, blood urea increased, constipation (What is constipation?), decreased appetite, diabetic neuropathy. During the same period patient was treated with ALMATOL (View Almatol Review and Almatol Label ), 8 HOUR BAYER (View 8-hour Bayer Review and 8-hour Bayer Label ), BLOPRESS (View Blopress Review and Blopress Label ), CIBENOL (View Cibenol Review and Cibenol Label ). Patient was hospitalized.

7019303-X | Pancreatic Carcinoma
on Sep 23, 2010 Female patient from UNITED STATES , 60 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Januvia (View Usage). Patient had the following side effects: pancreatic carcinoma. Januvia dosage: .

7018654-2 | Interstitial Lung Disease
on Sep 22, 2010 Female patient from JAPAN , 62 years of age, was diagnosed with diabetes mellitus, hypertension and was treated with Januvia (View Usage). After Januvia was administered, patient had the following side effects: interstitial lung disease. Januvia dosage: . During the same period patient was treated with MICARDIS (View Micardis Review and Micardis Label ). Patient was hospitalized.

7018652-9 | Blood Cholesterol Abnormal, Pancreatitis
Patient was taking Januvia (View Usage). Patient experienced the following unwanted or unexpected effects: blood cholesterol abnormal, pancreatitis on Sep 22, 2010 from UNITED STATES Additional patient health information: Female patient , 35 years of age, was diagnosed with type 2 diabetes mellitus and. Januvia dosage: . During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized.

7015618-X | Hypoaesthesia, Pain In Extremity, Paraesthesia
Adverse event was reported on Sep 21, 2010 by a Female patient taking Januvia (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus, rash (What is rash?) and. Location: UNITED STATES , 25 years of age, weighting 119.0 lb, Patient had the following side effects: hypoaesthesia, pain in extremity, paraesthesia. During the same period patient was treated with FLUOCINONIDE (View Fluocinonide Review and Fluocinonide Label ), METFORMIN (View Metformin Review and Metformin Label ).

7015613-0 | Gastrointestinal Pain
on Sep 20, 2010 Male patient from UNITED STATES , 50 years of age, was diagnosed with diabetes mellitus and was treated with Januvia (View Usage). After Januvia was administered, patient had the following side effects: gastrointestinal pain. Januvia dosage: . Patient was hospitalized.

7015612-9 | Clostridial Infection, Haematuria, Prothrombin Time Prolonged
on Sep 21, 2010 Male patient from UNITED STATES , 86 years of age, was diagnosed with type 2 diabetes mellitus, clostridial infection and was treated with Januvia (View Usage). Patient experienced the following unwanted or unexpected effects: clostridial infection, haematuria, prothrombin time prolonged. Januvia dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), LASIX (View Lasix Review and Lasix Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), FLAGYL (View Flagyl Review and Flagyl Label ). Patient was hospitalized and became disabled.

7015604-X | Pancreatic Cyst
Patient was taking Januvia (View Usage). Patient had the following side effects: pancreatic cyst on Sep 20, 2010 from UNITED STATES Additional patient health information: Female patient , 83 years of age, was diagnosed with diabetes mellitus and. Januvia dosage: . Patient was hospitalized.

7015596-3 | Basedow's Disease
Adverse event was reported on Sep 14, 2010 by a Male patient taking Januvia (View Usage) (Dosage: ) . Location: FRANCE , 59 years of age, After Januvia was administered, patient had the following side effects: basedow's disease. Patient was hospitalized.

7013919-2 | Purpura, Rash, Tenderness, Vasculitis
on Sep 22, 2010 Male patient from UNITED KINGDOM , 55 years of age, weighting 357.1 lb, was diagnosed with diabetes mellitus, hypertension and was treated with Januvia (View Usage). Patient experienced the following unwanted or unexpected effects: purpura, rash (What is rash?), tenderness, vasculitis (What is vasculitis?). Januvia dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METFORMIN (View Metformin Review and Metformin Label ).

7011032-1 | Arthralgia, Pancreatitis
on Sep 22, 2010 Male patient from UNITED STATES , 51 years of age, weighting 174.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Januvia (View Usage). Patient had the following side effects: arthralgia, pancreatitis. Januvia dosage: 100mg 1x Day Po.

7010871-0 | Alanine Aminotransferase Increased, Arthralgia, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Chronic Hepatitis, Gamma-glutamyltransferase Increased, Hepatic Fibrosis, Jaundice
Patient was taking Januvia (View Usage). After Januvia was administered, patient had the following side effects: alanine aminotransferase increased, arthralgia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, chronic hepatitis, gamma-glutamyltransferase increased, hepatic fibrosis, jaundice (What is jaundice?) on Sep 22, 2010 from FRANCE Additional patient health information: Male patient , 64 years of age, was diagnosed with type 2 diabetes mellitus and. Januvia dosage: . During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ). Patient was hospitalized.

7009984-9 | Sepsis
Adverse event was reported on Sep 16, 2010 by a Female patient taking Januvia (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: JAPAN , 84 years of age, Patient experienced the following unwanted or unexpected effects: sepsis (What is sepsis?). During the same period patient was treated with ZYLORIC (View Zyloric Review and Zyloric Label ), MYSLEE (View Myslee Review and Myslee Label ), OMEPRAL (View Omepral Review and Omepral Label ), MEVALOTIN (View Mevalotin Review and Mevalotin Label ), WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ), AMARYL (View Amaryl Review and Amaryl Label ), MAINTATE (View Maintate Review and Maintate Label ), LAC B (View Lac-b Review and Lac-b Label ). Patient was hospitalized.

7009981-3 | Abnormal Dreams, Asthenia, Blood Creatine Phosphokinase Increased, Chest Pain, Dizziness, Fatigue, Hyperhidrosis, Liver Function Test Abnormal, Myalgia
on Sep 17, 2010 Male patient from UNITED STATES , 72 years of age, weighting 242.5 lb, was diagnosed with type 2 diabetes mellitus and was treated with Januvia (View Usage). Patient had the following side effects: abnormal dreams, asthenia, blood creatine phosphokinase increased, chest pain (What is chest pain?), dizziness (What is dizziness?), fatigue, hyperhidrosis, liver function test abnormal, myalgia. Januvia dosage: . During the same period patient was treated with GLUCOTROL (View Glucotrol Review and Glucotrol Label ), FLOVENT HFA (View Flovent Hfa Review and Flovent Hfa Label ), SAW PALMETTO (View Saw Palmetto Review and Saw Palmetto Label ), VITAMIN E (View Vitamin E Review and Vitamin E Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ).

7009976-X | Dyspnoea
on Sep 10, 2010 Female patient from JAPAN , 63 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Januvia (View Usage). After Januvia was administered, patient had the following side effects: dyspnoea. Januvia dosage: . During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), GLYCORAN (View Glycoran Review and Glycoran Label ), LASIX (View Lasix Review and Lasix Label ), OLMETEC (View Olmetec Review and Olmetec Label ), LEVEMIR (View Levemir Review and Levemir Label ). Patient was hospitalized.

7008685-0 | Autoimmune Pancreatitis, Glycosylated Haemoglobin Increased
Patient was taking Januvia (View Usage). Patient experienced the following unwanted or unexpected effects: autoimmune pancreatitis, glycosylated haemoglobin increased on Sep 16, 2010 from JAPAN Additional patient health information: Male patient , 74 years of age, was diagnosed with type 2 diabetes mellitus, hyperlipidaemia, hypertension, angina pectoris and. Januvia dosage: . During the same period patient was treated with GLUFAST (View Glufast Review and Glufast Label ), LIPITOR (View Lipitor Review and Lipitor Label ), TENORMIN (View Tenormin Review and Tenormin Label ), BUFFERIN (View Bufferin Review and Bufferin Label ), DIOVAN (View Diovan Review and Diovan Label ).

7007825-7 | Obesity
Adverse event was reported on Sep 14, 2010 by a Female patient taking Januvia (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: FRANCE , 50 years of age, Patient had the following side effects: obesity (What is obesity?). During the same period patient was treated with INSULIN GLARGINE (View Insulin Glargine Review and Insulin Glargine Label ). Patient was hospitalized.

7007824-5 | Cardio-respiratory Arrest
on Sep 09, 2010 Female patient from JAPAN , 63 years of age, weighting 141.1 lb, was diagnosed with diabetes mellitus, back pain (What is back pain?), gastrointestinal ulcer, dyslipidaemia, schizophrenia and was treated with Januvia (View Usage). After Januvia was administered, patient had the following side effects: cardio-respiratory arrest. Januvia dosage: 1 Mg And Eumunae 2 Mg After Supper. During the same period patient was treated with LOXONIN (View Loxonin Review and Loxonin Label ), TAKEPRON (View Takepron Review and Takepron Label ), ADOFEED (View Adofeed Review and Adofeed Label ), GLYBURIDE (After The Breakfast) (View Glyburide Review and Glyburide Label ), EPADEL (View Epadel Review and Epadel Label ), METFORMIN HCL (Evening In The Morning) (View Metformin Hcl Review and Metformin Hcl Label ), CERCINE (View Cercine Review and Cercine Label ).

7006458-6 | Prothrombin Time Prolonged
on Sep 13, 2010 Male patient from JAPAN , 79 years of age, weighting 154.3 lb, was diagnosed with type 2 diabetes mellitus and was treated with Januvia (View Usage). Patient experienced the following unwanted or unexpected effects: prothrombin time prolonged. Januvia dosage: .

7006451-3 | Prothrombin Time Prolonged
Patient was taking Januvia (View Usage). Patient had the following side effects: prothrombin time prolonged on Sep 13, 2010 from JAPAN Additional patient health information: Male patient , 79 years of age, weighting 154.3 lb, was diagnosed with diabetes mellitus, atrial fibrillation (What is atrial fibrillation?), benign prostatic hyperplasia, lipids abnormal and. Januvia dosage: . During the same period patient was treated with WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), FLIVAS (View Flivas Review and Flivas Label ), MEVALOTIN (View Mevalotin Review and Mevalotin Label ), NOVORAPID (Two Units In Front Of The Supper 16 Units Before Breakfast) (View Novorapid Review and Novorapid Label ).

7006448-3 | Blood Creatinine Increased, Pyuria
Adverse event was reported on Sep 16, 2010 by a Male patient taking Januvia (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus, urinary tract infection (What is urinary tract infection?) and. Location: FRANCE , 65 years of age, After Januvia was administered, patient had the following side effects: blood creatinine increased, pyuria. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ). Patient was hospitalized.

7005731-5 | Hypoglycaemic Unconsciousness
on Sep 15, 2010 Female patient from JAPAN , 85 years of age, weighting 143.3 lb, was diagnosed with type 2 diabetes mellitus and was treated with Januvia (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemic unconsciousness. Januvia dosage: . During the same period patient was treated with GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), PIOGLITAZONE HYDROCHLORIDE (View Pioglitazone Hydrochloride Review and Pioglitazone Hydrochloride Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

7005730-3 | Rectal Haemorrhage
on Sep 15, 2010 Female patient from UNITED STATES , 59 years of age, was diagnosed with diabetes mellitus and was treated with Januvia (View Usage). Patient had the following side effects: rectal haemorrhage. Januvia dosage: . Patient was hospitalized.

7005721-2 | Pneumonia
Patient was taking Januvia (View Usage). After Januvia was administered, patient had the following side effects: pneumonia (What is pneumonia?) on Sep 16, 2010 from ITALY Additional patient health information: Female patient , 66 years of age, was diagnosed with type 2 diabetes mellitus and. Januvia dosage: . Patient was hospitalized.

7005718-2 | Pancreatitis Acute
Adverse event was reported on Sep 13, 2010 by a Male patient taking Januvia (View Usage) (Dosage: ) was diagnosed with diabetes mellitus, constipation (What is constipation?) and. Location: JAPAN , 65 years of age, weighting 158.7 lb, Patient experienced the following unwanted or unexpected effects: pancreatitis acute. During the same period patient was treated with GLYBURIDE (View Glyburide Review and Glyburide Label ), ACTOS (View Actos Review and Actos Label ), MAGLAX (View Maglax Review and Maglax Label ). Patient was hospitalized.

7005712-1 | Acute Myeloid Leukaemia
on Sep 15, 2010 Male patient from JAPAN , 60 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Januvia (View Usage). Patient had the following side effects: acute myeloid leukaemia. Januvia dosage: . During the same period patient was treated with BLOPRESS (View Blopress Review and Blopress Label ), NORVASC (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

7005710-8 | Sepsis
on Sep 15, 2010 Female patient from JAPAN , 84 years of age, was diagnosed with diabetes mellitus and was treated with Januvia (View Usage). After Januvia was administered, patient had the following side effects: sepsis (What is sepsis?). Januvia dosage: . During the same period patient was treated with ZYLORIC (View Zyloric Review and Zyloric Label ), MYSLEE (View Myslee Review and Myslee Label ), OMEPRAL (View Omepral Review and Omepral Label ), MEVALOTIN (View Mevalotin Review and Mevalotin Label ), WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ), AMARYL (View Amaryl Review and Amaryl Label ), MAINTATE (View Maintate Review and Maintate Label ), LAC B (View Lac-b Review and Lac-b Label ). Patient was hospitalized.

7001887-9 | Lipase Increased, Renal Impairment
Patient was taking Januvia (View Usage). Patient experienced the following unwanted or unexpected effects: lipase increased, renal impairment on Sep 14, 2010 from UNITED STATES Additional patient health information: Female patient , 70 years of age, was diagnosed with diabetes mellitus and. Januvia dosage: . Patient was hospitalized.

7001885-5 | Neutropenia
Adverse event was reported on Sep 09, 2010 by a Male patient taking Januvia (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus, urinary tract infection (What is urinary tract infection?) and. Location: FRANCE , 52 years of age, Patient had the following side effects: neutropenia. During the same period patient was treated with GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), CEFIXIME (View Cefixime Review and Cefixime Label ). Patient was hospitalized.

7001874-0 | Obesity
on Sep 14, 2010 Female patient from FRANCE , 50 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Januvia (View Usage). After Januvia was administered, patient had the following side effects: obesity (What is obesity?). Januvia dosage: . During the same period patient was treated with INSULIN GLARGINE (View Insulin Glargine Review and Insulin Glargine Label ). Patient was hospitalized.

6994580-X | Pancreatic Carcinoma, Pancreatic Disorder
on Sep 16, 2010 Female patient from UNITED STATES , 86 years of age, weighting 143.3 lb, was diagnosed with type 2 diabetes mellitus, gastrooesophageal reflux disease, neuropathy peripheral, anxiety (What is anxiety?), hypothyroidism, platelet aggregation, blood cholesterol and was treated with Januvia (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatic carcinoma, pancreatic disorder. Januvia dosage: . During the same period patient was treated with GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), NEXIUM (View Nexium Review and Nexium Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TEMODAL (View Temodal Review and Temodal Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

6994579-3 | Glycosylated Haemoglobin Increased, Pancreatitis Acute
Patient was taking Januvia (View Usage). Patient had the following side effects: glycosylated haemoglobin increased, pancreatitis acute on Sep 15, 2010 from UNITED STATES Additional patient health information: Male patient , 59 years of age, weighting 235.9 lb, was diagnosed with type 2 diabetes mellitus and. Januvia dosage: . During the same period patient was treated with ONGLYZA (View Onglyza Review and Onglyza Label ), GLYBURIDE AND METFORMIN HYDROCHLORIDE (View Glyburide And Metformin Hydrochloride Review and Glyburide And Metformin Hydrochloride Label ), ACTOS (View Actos Review and Actos Label ). Patient was hospitalized and became disabled.

6992706-5 | Gastritis, Gastritis Erosive, Gastrointestinal Haemorrhage, Haemoglobin Decreased, Microcytic Anaemia, Platelet Count Decreased, Red Blood Cell Count Decreased, Reflux Oesophagitis
Adverse event was reported on Sep 03, 2010 by a Male patient taking Januvia (View Usage) (Dosage: ) was diagnosed with diabetes mellitus, hyperglycaemia, hypoaesthesia, hypercholesterolaemia, blood cholesterol, nocturia and. Location: JAPAN , 66 years of age, weighting 147.7 lb, After Januvia was administered, patient had the following side effects: gastritis, gastritis erosive, gastrointestinal haemorrhage, haemoglobin decreased, microcytic anaemia, platelet count decreased, red blood cell count decreased, reflux oesophagitis. During the same period patient was treated with VOLTAREN (Before Breakfast, After Dinner) (View Voltaren Review and Voltaren Label ), BASEN OD (View Basen Od Review and Basen Od Label ), OPALMON (View Opalmon Review and Opalmon Label ), CRESTOR (View Crestor Review and Crestor Label ), GLYBURIDE (2.5 Mg - 0mg - 1.25 Mg) (View Glyburide Review and Glyburide Label ), VESICARE (After Dinner) (View Vesicare Review and Vesicare Label ).

6992698-9 | Agranulocytosis
on Sep 13, 2010 Female patient from JAPAN , 86 years of age, weighting 99.21 lb, was diagnosed with type 2 diabetes mellitus, hypertension, reflux oesophagitis, osteoporosis (What is osteoporosis?), insomnia, organising pneumonia, prophylaxis, psychosomatic disease and was treated with Januvia (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis. Januvia dosage: . During the same period patient was treated with BLOPRESS (View Blopress Review and Blopress Label ), PARIET (View Pariet Review and Pariet Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), AMOBAN (View Amoban Review and Amoban Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), BACTRAMIN (View Bactramin Review and Bactramin Label ), ISCOTIN (View Iscotin Review and Iscotin Label ), DEPAS (View Depas Review and Depas Label ). Patient was hospitalized.

6992687-4 | Erythema Nodosum, Nasopharyngitis
on Sep 10, 2010 Female patient from JAPAN , 66 years of age, was diagnosed with diabetes mellitus, hypertension, dyslipidaemia and was treated with Januvia (View Usage). Patient had the following side effects: erythema nodosum, nasopharyngitis. Januvia dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), BLOPRESS (View Blopress Review and Blopress Label ), LIPOBLOCK (View Lipoblock Review and Lipoblock Label ), CRAVIT (View Cravit Review and Cravit Label ), MUCOSOLVAN L (View Mucosolvan L Review and Mucosolvan L Label ), SINGULAIR (View Singulair Review and Singulair Label ). Patient was hospitalized.

6988377-4 | Blood Creatine Phosphokinase Increased, Myalgia
Patient was taking Januvia (View Usage). After Januvia was administered, patient had the following side effects: blood creatine phosphokinase increased, myalgia on Sep 10, 2010 from JAPAN Additional patient health information: Female patient , 58 years of age, weighting 156.5 lb, was diagnosed with blood glucose abnormal, dyslipidaemia, arteriosclerosis, reflux oesophagitis, chronic hepatitis, hypertension and. Januvia dosage: . During the same period patient was treated with MEVALOTIN (View Mevalotin Review and Mevalotin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), OMEPRAL (View Omepral Review and Omepral Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), MICARDIS (View Micardis Review and Micardis Label ).

6988374-9 | Cough, Erythema Of Eyelid, Eyelid Oedema, Face Oedema, Oculomucocutaneous Syndrome, Oropharyngeal Pain, Rhinorrhoea
Adverse event was reported on Sep 08, 2010 by a Female patient taking Januvia (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus, diabetic neuropathy and. Location: JAPAN , 57 years of age, weighting 108.0 lb, Patient experienced the following unwanted or unexpected effects: cough, erythema of eyelid, eyelid oedema, face oedema, oculomucocutaneous syndrome, oropharyngeal pain, rhinorrhoea. During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), EPALDOSE (View Epaldose Review and Epaldose Label ), LORFENAMIN (View Lorfenamin Review and Lorfenamin Label ), MOBIC (View Mobic Review and Mobic Label ).

6988373-7 | Eczema, Pyrexia, Sepsis
on Sep 10, 2010 Female patient from JAPAN , 80 years of age, was diagnosed with diabetes mellitus and was treated with Januvia (View Usage). Patient had the following side effects: eczema (What is eczema?), pyrexia, sepsis (What is sepsis?). Januvia dosage: . During the same period patient was treated with ZYLORIC (View Zyloric Review and Zyloric Label ).

6988370-1 | Cerebral Infarction
on Sep 10, 2010 Male patient from JAPAN , 63 years of age, weighting 138.9 lb, was diagnosed with diabetes mellitus and was treated with Januvia (View Usage). After Januvia was administered, patient had the following side effects: cerebral infarction. Januvia dosage: . Patient was hospitalized.

6986058-4 | Skin Cancer
Patient was taking Januvia (View Usage). Patient experienced the following unwanted or unexpected effects: skin cancer (What is skin cancer?) on Sep 13, 2010 from FRANCE Additional patient health information: Female patient , 80 years of age, was diagnosed with type 2 diabetes mellitus, hypertension and. Januvia dosage: . During the same period patient was treated with GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), HYDROCHLOROTHIAZIDE AND LOSARTAN POTASSIUM (View Hydrochlorothiazide And Losartan Potassium Review and Hydrochlorothiazide And Losartan Potassium Label ), URSODIOL (View Ursodiol Review and Ursodiol Label ), FLECAINIDE ACETATE (View Flecainide Acetate Review and Flecainide Acetate Label ), DIACEREIN (View Diacerein Review and Diacerein Label ).

6986053-5 | Adverse Event, Dizziness, Dyspnoea, Loss Of Consciousness
Adverse event was reported on Sep 10, 2010 by a Female patient taking Januvia (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 76 years of age, Patient had the following side effects: adverse event, dizziness (What is dizziness?), dyspnoea, loss of consciousness. During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized.

6985570-1 | Vascular Purpura
on Sep 13, 2010 Male patient from FRANCE , 81 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Januvia (View Usage). After Januvia was administered, patient had the following side effects: vascular purpura. Januvia dosage: . During the same period patient was treated with FLUINDIONE (View Fluindione Review and Fluindione Label ), AMIODARONE HYDROCHLORIDE (View Amiodarone Hydrochloride Review and Amiodarone Hydrochloride Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), ACETAMINOPHEN AND TRAMADOL HYDROCHLORIDE (View Acetaminophen And Tramadol Hydrochloride Review and Acetaminophen And Tramadol Hydrochloride Label ), KETOCONAZOLE (View Ketoconazole Review and Ketoconazole Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), METFORMIN (View Metformin Review and Metformin Label ), ACEBUTOLOL HYDROCHLORIDE (View Acebutolol Hydrochloride Review and Acebutolol Hydrochloride Label ). Patient was hospitalized.

6985563-4 | Joint Swelling, Pyrexia
on Sep 09, 2010 Female patient from JAPAN , 78 years of age, weighting 149.9 lb, was diagnosed with type 2 diabetes mellitus, dyslipidaemia and was treated with Januvia (View Usage). Patient experienced the following unwanted or unexpected effects: joint swelling, pyrexia. Januvia dosage: . During the same period patient was treated with ACTOS (View Actos Review and Actos Label ), SEIBULE (View Seibule Review and Seibule Label ), GLUFAST (View Glufast Review and Glufast Label ), NOVORAPID (View Novorapid Review and Novorapid Label ), LIVALO (View Livalo Review and Livalo Label ).

6981177-0 | Blood Creatine Phosphokinase Increased, Myalgia, Rhabdomyolysis
Patient was taking Januvia (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, myalgia, rhabdomyolysis on Sep 02, 2010 from FRANCE Additional patient health information: Female patient , 75 years of age, weighting 143.3 lb, was diagnosed with diabetes mellitus, hypercholesterolaemia, gastrooesophageal reflux disease, depression (What is depression?), hypertension, myocardial ischaemia, hypothyroidism and. Januvia dosage: . During the same period patient was treated with ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), PAROXETINE HYDROCHLORIDE (View Paroxetine Hydrochloride Review and Paroxetine Hydrochloride Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), ASPIRIN LYSINE (View Aspirin Lysine Review and Aspirin Lysine Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized and became disabled.